What NICO.LAB does

Nicolab is a healthcare technology company that develops an AI-powered stroke workflow and emergency care platform for hospitals and stroke networks. The company's product portfolio centers on the StrokeViewer AI suite — a set of proprietary computer vision algorithms that detect large vessel occlusions, intracerebral hemorrhages, and quantify ischemic core and penumbra from CT and MR brain images, with clinically validated sensitivity and specificity metrics. These AI modules are integrated into a cloud-native collaboration platform that enables secure real-time image sharing, structured notifications, and case review across hospital sites, and is paired with Nicolab Assist, a mobile application featuring an FDA-cleared DICOM viewer that streams full imaging series in under 10 seconds. The platform reports measured clinical impact including 13 minutes faster door-to-groin time, 54 minutes reduction in time to expert notification, 2.4 days reduction in hospital length of stay, and 12% reduction in severe long-term disability in early-window transfer patients.

Nicolab was founded in 2015 in Amsterdam by researchers, developers, and physicians from the MR CLEAN clinical trial and is incorporated as NICo-Lab B.V. The company has accumulated an unusually broad set of medical device clearances for its size, including FDA 510(k), CE, UKCA, TGA, MedSafe, Taiwan FDA, Thai FDA, CDSCO (India), Swissmedic, and Singapore HSA, alongside EU MDR, UK MDR, ISO 13485:2016, ISO/IEC 27001:2022, and NEN 7510-1 certifications. It operates across 10+ countries with landmark enterprise deployments including Queensland Health (36 hospitals), Health New Zealand (up to 30 hospitals), the Victorian Stroke Telemedicine service (21 hospitals), and the UMBRELLA consortium (5 hub plus 11-15 spoke hospitals). The platform has assisted more than 170,000 patients cumulatively and supported more than 60,000 stroke pathways in 2025.

Nicolab monetizes primarily through multi-year SaaS subscription contracts sold directly to hospital systems and government health services, complemented by regional channel partnerships: Philips and N-Vascular Technology for India, Veritas Biomedical for Taiwan, Human Bytes for the Nordic region, and the Harrison.ai Open Platform globally. Pricing is quote-based and negotiated per deployment. In July 2025 the platform was rebranded from StrokeViewer to Nicolab, signaling a strategic expansion beyond stroke into broader acute care clinical communication. The company is described as an Australian-based public unlisted company with approximately 75% of shareholders based in Australia and an international board; total disclosed funding to date is approximately $12.3 million, including a $10 million round led by Canaccord Genuity in April 2021 and a European Innovation Council Accelerator grant in 2022-2023.

Name

NICO.LAB

Legal name

NICo-Lab B.V.

Website

https://nicolab.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Nicolab is an Amsterdam-based healthcare technology company offering an AI-powered stroke workflow and emergency care platform. Its StrokeViewer AI suite detects large vessel occlusions and hemorrhages on brain scans and is deployed across 10+ countries via multi-year SaaS contracts with hospital systems.

Ownership category

akta.pro rank

Product category

AI Stroke Imaging Software

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery) (HLACAMAL)

Keywords

• AI stroke imaging
• Stroke workflow platform
• Medical imaging AI
• Acute care coordination
• Telestroke software

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. SaaS Subscription - StrokeViewer Platform: Software-as-a-service image processing application provided to hospitals and healthcare systems under subscription agreements. The platform is offered as a subscription service with implementation and support included.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels8 records

Core offering

NICO.LAB develops and sells the Nicolab / StrokeViewer platform, a cloud-native, AI-powered stroke workflow and emergency care software that combines AI-assisted triaging (LVO, hemorrhage, CT/MR perfusion, collateral scoring), an FDA-cleared mobile DICOM diagnostic viewer, and real-time secure image sharing between hospitals and stroke specialists. It is delivered to hospitals, stroke networks, and government health services primarily under multi-year SaaS subscriptions.

Product overview

Nicolab offers an AI-powered stroke workflow and emergency care platform (rebranded from StrokeViewer in July 2025) consisting of: the Nicolab Platform as the core cloud-native infrastructure enabling real-time imaging access and care team collaboration; the StrokeViewer AI suite of algorithms for stroke detection including LVO Triaging, Hemorrhage Triaging, and Perfusion analysis (both CT and MR); the Nicolab Assist mobile application for on-the-go diagnostics; and the DICOM Viewer for certified diagnostic imaging. The platform supports over 170,000 patients and operates across 10+ countries.

Differentiator

Problem solved

Functional benefit

Brands

• StrokeViewer: AI algorithms for acute stroke care - includes LVO triaging, hemorrhage triaging, CT perfusion, MR perfusion, and collateral assessment algorithms.

Products and services

• Nicolab Platform AI-powered cloud-native stroke workflow and emergency care platform that enables real-time access to medical imaging, AI-assisted diagnostics, and seamless collaboration across acute care teams. Connects hospitals and regions via secure image sharing, patient timelines, and communication tools. Sold to hospitals, stroke networks, and government health authorities under multi-year SaaS subscriptions.
• StrokeViewer AI Suite of proprietary AI algorithms for acute stroke diagnosis, including LVO (Large Vessel Occlusion) triaging, intracerebral hemorrhage triaging, CT and MR perfusion analysis, and collateral scoring. Algorithms analyze CT and MRI brain imaging to detect occlusions, hemorrhages, and assess brain tissue viability for treatment planning.
• Nicolab Assist (Mobile Application) Mobile application enabling physicians to view patient CT scans on their devices, access patient timelines, and collaborate with colleagues in real-time from anywhere, facilitating communication and faster treatment decisions for stroke and acute care teams.
• FDA-cleared Mobile DICOM Viewer Clinically certified, FDA-cleared mobile DICOM viewer that streams full DICOM series in under 10 seconds, enabling experts to interpret high-quality diagnostic images on mobile devices from any location. Approved for diagnostic use in the US market.

Quantifiable outcome

• 13 minutes faster Door-to-Groin time for Late window transfer patients
• +7 more outcomes

Named customers10 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Partnerships

18 partnerships are on record, tiered core, flagship, regional, exploratory and strategic.

• N-Vascular TechnologycoreChannel Partner/ Reseller/ Distributor · 1 June 2026Strategic partnership to expand Nicolab's StrokeViewer platform across India, supporting hospitals and stroke networks with AI-enabled acute stroke imaging and workflow technology.
• Human BytescoreStrategic or Co-development Partner · 7 January 2026Strategic partnership for stroke coordination across Nordic region. Human Bytes integrates Nicolab's StrokeViewer into their portfolio of AI solutions for acute care in Denmark, Sweden, Norway, and Finland. Partnership aims to empower acute care physicians with quick and reliable access to vital information. About 50,000 people across Nordic countries suffer from stroke every year with 500,000 living with consequences.
• Harrison.aicoreStrategic or Co-development Partner · 1 November 2025Nicolab joins Harrison.ai Open Platform as a launch partner, making its FDA- and globally approved StrokeViewer AI solution accessible through a zero-markup model that removes traditional platform barriers and accelerates adoption in stroke care.
• PhilipscoreChannel Partner/ Reseller/ Distributor · 1 November 2025Collaboration with Philips to advance stroke care in India. Philips and Nicolab launched StrokeViewer in India enabling faster, AI-powered stroke diagnosis, seamless care coordination, and improved patient outcomes across the country.
• Regione LombardiaflagshipStrategic or Co-development Partner · 1 September 2025Nicolab and Regione Lombardia selected as pilots for InnoMatch EU-funded project (European Innovation Council EIC Innovation Procurement Programme). Project helps innovative SMEs gain access to procurement markets through pilot testing with public and private buyers across Europe.
• Health New Zealand - Te Whatu OraflagshipStrategic or Co-development Partner · 1 August 2025Landmark partnership with Health New Zealand – Te Whatu Ora, Capital, Coast and Hutt Valley, and University of Otago, Wellington, to roll out AI-powered StrokeViewer across up to 30 hospitals nationwide in New Zealand.
• Mediterraneo HospitalregionalStrategic or Co-development Partner · 1 July 2025Nicolab and Mediterraneo Hospital launched Greece's first AI-powered stroke network in partnership with Philips. Connecting Athens with Santorini and Paros, the network uses StrokeViewer to enable fast, AI-assisted stroke diagnosis and treatment across the Greek islands.
• Queensland HealthflagshipStrategic or Co-development Partner · 1 May 2025Queensland Health Standing Offer Arrangement (SOA) to implement StrokeViewer across 36 hospitals, making it Australia's largest AI-driven stroke imaging rollout. Trial sites include Royal Brisbane and Women's Hospital, Prince Charles Hospital, Caboolture, Redcliffe, Sunshine Coast, and regional hospitals.
• UMBRELLA Consortium (Vall d'Hebron Research Institute & Siemens Healthineers)flagshipStrategic or Co-development Partner · 1 October 2024Nicolab participates in UMBRELLA consortium co-led by Vall d'Hebron Research Institute (VHIR) and Siemens Healthineers, with nearly €27 million funding from Innovative Health Initiative. Nicolab will deploy StrokeViewer across 5 hub hospitals and 11-15 spoke hospitals. Over 20 public and private partners focused on improving stroke care pathway from diagnosis to rehabilitation across Europe.
• WellumioexploratoryTechnology or Integration · 1 October 2024Memorandum of Understanding to explore integration of Wellumio's Axana portable MRI device with Nicolab's StrokeViewer platform to enhance rapid stroke diagnosis and streamline clinical workflows.
• Veritas BiomedicalregionalChannel Partner/ Reseller/ Distributor · 1 August 2024Partnership to bring AI stroke solution to Taiwan. StrokeViewer will be offered through Veritas's extensive network, providing healthcare facilities across Taiwan with cutting-edge AI-powered stroke care solutions.
• Gold Coast Hospital and Health ServicesregionalStrategic or Co-development Partner · 1 April 2024Reference site agreement to deliver AI-powered stroke software StrokeViewer to Gold Coast Health. Solution revolutionises stroke care at Gold Coast Hospital and Health Services.
• Titan Neuroscience Research AustraliaexploratoryStrategic or Co-development Partner · 1 April 2024Memorandum of Understanding for development of collaborative partnership. Nicolab is a publicly unlisted Australian-based company partnering with Australian research institutions.
• Victorian Stroke Telemedicine Service (VST)coreStrategic or Co-development Partner · 1 May 2023Prestigious 3-year contract to supply stroke workflow software and advanced AI diagnostics for Victorian Stroke Telemedicine service. VST connects healthcare professionals across multiple hospitals to deliver exceptional stroke care. Network connects 19 hospitals in Victoria and 2 hospitals in Tasmania to stroke specialists.
• Global Neurosciences Institute (GNI)strategicStrategic or Co-development Partner · 1 August 2022Collaboration with GNI to help improve patient outcomes. GNI is committed to changing lives and transforming healthcare throughout hospitals and outpatient clinics in Delaware, Pennsylvania, and New Jersey with innovative neurological emergency room.
• RAD-xstrategicTechnology or Integration · 1 May 2022Research collaboration where RAD-x makes available its large image repository (400,000+ imaging procedures per year across Germany, Switzerland, and France) to Nicolab for training AI algorithms. Nicolab assists RAD-x in adoption of AI-analysed diagnosis support.
• Amsterdam UMCcoreStrategic or Co-development PartnerLong-standing research partnership with Amsterdam UMC (Academic Medical Center). Partnership awarded grant to improve stroke treatment with AI software using MR images. Company was established in 2015 following the MR CLEAN clinical trial conducted at Amsterdam UMC.
• NHS LothianregionalStrategic or Co-development PartnerNHS Lothian conducted retrospective accuracy assessment of StrokeViewer in developing stroke thrombectomy UK service. Study demonstrated high sensitivity (93%) and specificity (94%) for large vessel occlusions in quaternary stroke center.

Scale indicators14 records

Recent moves11 records

Expansion highlights7 records

Direct peers

• RapidAI: RapidAI is a leading AI platform for stroke and other neurovascular conditions, offering LVO detection, perfusion analysis, and workflow tools. It directly competes with Nicolab's StrokeViewer in the same hospital customer base with overlapping AI imaging capabilities.
• Viz.ai: Viz.ai provides AI-powered care coordination, most notably for LVO stroke triage and large-vessel-occlusion detection, with mobile image sharing to specialists. It competes head-to-head with Nicolab's StrokeViewer LVO triaging and connected network workflows.
• Brainomix: Brainomix offers AI-based imaging biomarkers (e.g., e-Stroke suite for LVO and ASPECTS) for stroke decision support. It serves the same hospital neurology/stroke centers as Nicolab with comparable AI imaging and workflow functionality.

Broad incumbents

• Aidoc: Aidoc is a broader radiology AI platform covering multiple conditions (PE, hemorrhage, stroke, etc.) for hospital imaging workflows. It overlaps with Nicolab in AI-driven CT brain imaging but operates across a wider imaging portfolio.
• Qure.ai: Qure.ai provides AI for head CT and chest X-ray interpretation, including ICH and stroke triage, deployed globally. It competes with Nicolab in head CT AI triage while serving a broader diagnostic imaging market.
• Philips: Philips is a major healthcare technology and imaging vendor that is also a channel/distribution partner for Nicolab in India. As a broader incumbent, it competes in acute care imaging informatics and could expand its own stroke AI offerings.
• Siemens Healthineers: Siemens Healthineers is a global imaging modality and informatics vendor and co-leads the UMBRELLA consortium with Nicolab. It competes at the platform/integrated-imaging level and could bundle stroke AI capabilities alongside its CT/MR systems.
• Penumbra (Real-Time AI / Stroke franchise): Penumbra is a neurovascular device company with a growing stroke care digital/AI franchise and a dedicated stroke coordinator offering. It is an adjacent incumbent in the stroke treatment workflow where Nicolab's imaging/triage AI integrates upstream.

Emerging players

• Avicenna.ai: Avicenna.ai develops AI solutions for medical imaging including stroke triage and workflow automation. It is a smaller, emerging competitor in the same AI stroke imaging category as Nicolab.
• Harrison.ai: Harrison.ai is an Australian-based healthcare AI company building diagnostic AI across multiple specialties and operates an Open Platform where Nicolab is a launch partner. It is an adjacent AI player with overlapping go-to-market in hospitals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/nico-lab
• Xx.com/Nicolab_AI

Compliance15 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NICO.LAB